Enzalutamide-resistant LNCaP ARF877L Mutation KI model
We have established an enzalutamide-resistant (LNCaP AR-F877L mutation) KI prostate cancer model to support the development of next-generation therapeutics. An...
Continue ReadingKnowledge Library
Recent Advances in Library Synthesis to Accelerate Medicinal Chemistry Research
Learn how parallel medicinal chemistry (PMC) and high-throughput experimentation (HTE) can provide a more focused approach to target molecules, resulting...
Continue Reading
Gout Models
As part of our autoimmune and inflammatory disease platform, we provide an extensive panel of monosodium urate (MSU) induced gout...
Continue Reading Drug Resistant Models
Comprehensive portfolio of drug resistant models representing clinically relevant mechanisms of resistance: 10+ cancer types 25+ key targets 30+ leading...
Continue Reading Cancer Pharmacology Services
Offering a wide range of targeted oncology services and translational models. Our comprehensive platform includes: in vitro biochemical, biophysical, and...
Continue Reading Large Animal Disease Models
Providing a comprehensive panel of large animal disease models across multiple species, including NHP, mini-pig, dog, and rabbit. Models for...
Continue Reading Autoimmune and Inflammatory Disease Models
Comprehensive platform of over 40 disease models (including NHPs and other large animals), covering a wide range of indications and...
Continue Reading Immune Profiling Platform
We offer an extensive panel of cutting-edge immune profiling and biomarker discovery services to support: Target discovery and validation Drug...
Continue Reading Tumor Cell Panel | Screening Services
Comprehensive cell line screening assays integrated with downstream pharmacological services Cell panel of 600+ human cancer cell lines for single...
Continue Reading